Home LiteratureArticle Details
PMID: 10517735 Published · ppublish English Clinical Trial Comparative Study Journal Article

Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension.

Circulation ·Vol. 100 ·No. 15 ·1999-10-12 ·Pages 1635-8

Uzu T, Kimura G

Abstract

Recently, we found that sodium restriction shifted the circadian rhythm of blood pressure from nondipper to dipper in patients with the sodium-sensitive essential hypertension. This study examined whether diuretics can transform the circadian rhythm of blood pressure from nondipper to dipper. We studied 21 patients with essential hypertension during both a baseline period and a period of treatment with hydrochlorothiazide (25 mg daily). The periods lasted 4 weeks each. Twenty-four hour ambulatory blood pressures were measured on the same day of the week at the end of the each period. In nondippers (n=11), but not in dippers (n=10), a significant interaction existed between diuretic therapy and nocturnal fall in systolic and diastolic blood pressure, which indicated that the degree of nocturnal blood pressure fall was affected by diuretic therapy. Nocturnal fall, which was diminished in nondippers, was restored by diuretic therapy with hydrochlorothiazide, indicating that the circadian rhythm of blood pressure shifted from nondipper to dipper patterns. The present study demonstrated that diuretics can restore nocturnal blood pressure decline in a manner similar to sodium restriction, which suggests that the kidneys and sodium metabolism may play important roles in the genesis of the circadian rhythm of blood pressure. Diuretic-based treatment may have an additional therapeutic advantage of reducing the risk for cardiovascular complications by transforming the circadian rhythm of blood pressure.

MeSH Terms
Aged Antihypertensive Agents/pharmacology,therapeutic use Blood Pressure/drug effects,physiology Circadian Rhythm/drug effects Diuretics Female Heart Rate/drug effects Humans Hydrochlorothiazide/pharmacology,therapeutic use Hypertension/classification,drug therapy,physiopathology Kidney/drug effects,physiopathology Male Middle Aged Natriuresis/drug effects Sodium/metabolism Sodium Chloride Symporter Inhibitors/pharmacology,therapeutic use
Chemicals
Antihypertensive Agents Diuretics Sodium Chloride Symporter Inhibitors Hydrochlorothiazide Sodium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Uzu T
Division of Nephrology, National Cardiovascular Center, Osaka, Japan.
Kimura G
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
1999-10-12
Pages
1635-8
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com